#17473
#17474
Re: Farmas USA
#17475
Re: Farmas USA
Una que puede???? y que funcione la droga porfa¡¡¡¡¡¡¡
PTN..CRANBURY, NJ – September 10, 2012 – Palatin Technologies, Inc. (NYSE MKT: PTN) today announced that the last patient has completed treatment in its Phase 2B clinical trial evaluating the efficacy and safety of bremelanotide for treatment of female sexual dysfunction (FSD). Database lock is expected by the end of September and top-line trial results are expected in the first-half of next quarter.
#17476
Re: Farmas USA
#17477
Re: Farmas USA
#17478
Re: Farmas USA
#17479
Re: Farmas USA
#17480